Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Artru

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 15, 2018
Towards a RAS mutation status in a single day for patients with advanced colorectal cancers. Authors' replyAstrid Lièvre, Jean-Louis Merlin, Jean-Christophe Sabourin, et al.
Gastroenterologie Clinique Et Biologique|December 8, 2006
Esophagus cancerJean-François Seitz, Laetitia Dahan, Jacques Jacob, et al.
European Journal of Endocrinology|April 9, 2008
Mifepristone for ectopic ACTH secretion in metastatic endocrine carcinomas: report of two casesPhilippe A Cassier, Sawsan Abou-Amara-Olivieri, Pascal Artru, et al.
American Journal of Clinical Oncology|June 11, 2003
Bimonthly leucovorin, infusion 5-fluorouracil, hydroxyurea, and irinotecan (FOLFIRI-2) for pretreated metastatic colorectal cancerMay Mabro, Christophe Louvet, Thierry André, et al.
Targeted Oncology|February 6, 2023
Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French PerspectiveCindy Neuzillet, Pascal Artru, Eric Assenat, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 22, 2023
Digital tool to identify and monitor regorafenib-associated hand-foot skin reactions: A proof-of-concept study protocolRomain Coriat, Vincent Sibaud, Vincent Bourgeois, et al.
Clinics and Research in Hepatology and Gastroenterology|July 5, 2015
Complete pathological response of unresectable liver metastases from colorectal cancer after trans-arterial chemoembolization with drug-eluting beads loaded with irinotecan (DEBIRI) and concomitant systemic FOLFOX: A case report from the FFCD 1201 trialSimon Pernot, Pascal Artru, François Mithieux, et al.
Targeted Oncology|November 2, 2017
Trastuzumab in Combination with FOLFIRI in Patients with Advanced HER2-Positive Gastro-Esophageal Adenocarcinoma: A Retrospective Multicenter AGEO StudyAziz Zaanan, Juliette Palle, Emilie Soularue, et al.
Annals of Translational Medicine|February 8, 2021
Endoscopic ultrasound efficacy in staging gastric linitis plastica lesion: a retrospective multicentric French studyStephanie Morgant, Pascal Artru, Ammar Oudjit, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 4, 2017
Gemcitabine as second-line chemotherapy after Folfirinox failure in advanced pancreatic adenocarcinoma: A retrospective studyJuliette Viaud, Clémence Brac, Pascal Artru, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 15, 2018
Towards a RAS mutation status in a single day for patients with advanced colorectal cancers. Authors' replyAstrid Lièvre, Jean-Louis Merlin, Jean-Christophe Sabourin, et al.
Gastroenterologie Clinique Et Biologique|December 8, 2006
Esophagus cancerJean-François Seitz, Laetitia Dahan, Jacques Jacob, et al.
European Journal of Endocrinology|April 9, 2008
Mifepristone for ectopic ACTH secretion in metastatic endocrine carcinomas: report of two casesPhilippe A Cassier, Sawsan Abou-Amara-Olivieri, Pascal Artru, et al.
American Journal of Clinical Oncology|June 11, 2003
Bimonthly leucovorin, infusion 5-fluorouracil, hydroxyurea, and irinotecan (FOLFIRI-2) for pretreated metastatic colorectal cancerMay Mabro, Christophe Louvet, Thierry André, et al.
Targeted Oncology|February 6, 2023
Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French PerspectiveCindy Neuzillet, Pascal Artru, Eric Assenat, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 22, 2023
Digital tool to identify and monitor regorafenib-associated hand-foot skin reactions: A proof-of-concept study protocolRomain Coriat, Vincent Sibaud, Vincent Bourgeois, et al.
Clinics and Research in Hepatology and Gastroenterology|July 5, 2015
Complete pathological response of unresectable liver metastases from colorectal cancer after trans-arterial chemoembolization with drug-eluting beads loaded with irinotecan (DEBIRI) and concomitant systemic FOLFOX: A case report from the FFCD 1201 trialSimon Pernot, Pascal Artru, François Mithieux, et al.
Targeted Oncology|November 2, 2017
Trastuzumab in Combination with FOLFIRI in Patients with Advanced HER2-Positive Gastro-Esophageal Adenocarcinoma: A Retrospective Multicenter AGEO StudyAziz Zaanan, Juliette Palle, Emilie Soularue, et al.
Annals of Translational Medicine|February 8, 2021
Endoscopic ultrasound efficacy in staging gastric linitis plastica lesion: a retrospective multicentric French studyStephanie Morgant, Pascal Artru, Ammar Oudjit, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 4, 2017
Gemcitabine as second-line chemotherapy after Folfirinox failure in advanced pancreatic adenocarcinoma: A retrospective studyJuliette Viaud, Clémence Brac, Pascal Artru, et al.
Pageof 9